Disease | gastroesophageal reflux disease |
Phenotype | C0017168|gastroesophageal reflux disease |
Sentences | 27 |
PubMedID- 24941823 | Objective: to investigate the association between esophageal motility and acid reflux in patients with gastroesophageal reflux disease (gerd). |
PubMedID- 20040914 | Arbaclofen placarbil decreases postprandial reflux in patients with gastroesophageal reflux disease. |
PubMedID- 23350046 | Transient les relaxation (tlesr) with volume reflux is considered to be a major mechanism of symptomatic gastroesophageal reflux in patients with gastroesophageal reflux disease (gerd).8-10 during volume reflux, the entire surface of the distal esophagus is thought to be exposed to gastric acid. |
PubMedID- 24676289 | Influence of exercise testing in gastroesophageal reflux in patients with gastroesophageal reflux disease. |
PubMedID- 23875101 | The aims of this study were to determine whether obesity is associated with gastroesophageal reflux in patients with gastroesophageal reflux disease and to identify the factors affecting increased acid exposure in obese patients. |
PubMedID- 23128301 | Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy. |
PubMedID- 21675271 | Aim: to study informative value of 24-h ph monitoring in registration of gastroesophageal and duodenogastroesophageal reflux (ger, dger) in patients with gastroesophageal reflux disease (gerd) before and after surgical treatment. |
PubMedID- 21822428 | The histological and immunohistochemical aspects of bile reflux in patients with gastroesophageal reflux disease. |
PubMedID- 22862140 | Small volume acid reflux in gastroesophageal reflux disease patients with hiatal hernia is only detectable by ph-metry but not by multichannel intraluminal impedance. |
PubMedID- 23669304 | An alginate-antacid formulation localizes to the acid pocket to reduce acid reflux in patients with gastroesophageal reflux disease. |
PubMedID- 20838342 | The clinical consequence is rebound acid secretion which may induce dyspeptic symptoms in healthy individuals and exacerbate reflux symptoms in patients with gastroesophageal reflux disease. |
PubMedID- 22046769 | The pathological gastroesophageal reflux disease may lead to the gastroesophageal reflux disease (gerd), manifested as a spectrum of conditions including erosive esophagitis, barrett esophagus and has been linked to the development of adenocarcinoma of the esophagus. |
PubMedID- 25392612 | The gastroesophageal reflux disease–health-related quality of life scale (gerd-hrql) was used to assess the severity of reflux.14 the gerd-hrql is a disease-specific, 10-question, 6-point likert-type scale identifying symptoms such as heartburn and bloating. |
PubMedID- 25407279 | Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study. |
PubMedID- 21602991 | Nocturnal weakly acidic reflux is as common as acid reflux in patients with gastroesophageal reflux disease, and predominates later in the night. |
PubMedID- 25847137 | Validated questionnaires such as gastroesophageal reflux disease health-related quality of life (gerd-hrql), reflux symptom index (rsi) and achalasia disease-specific health-related quality of life were obtained pre- and postoperatively. |
PubMedID- 22837877 | Not all reflux episodes occurring in patients with gastroesophageal reflux disease (gerd) are accompanied by reflux symptoms. |
PubMedID- 25587615 | Autofluorescence imaging endoscopy for predicting acid reflux in patients with gastroesophageal reflux disease. |
PubMedID- 24557959 | Conclusion: speed of food intake has no significant impact on acidic reflux attacks in patients with gastroesophageal reflux disease. |
PubMedID- 22629750 | The article presents research data of duodenogastral reflux (dgr) role in patients with gastroesophageal reflux disease. |
PubMedID- 25172606 | Gastrointestinal symptoms were evaluated with gastroesophageal reflux disease-health related quality of life (gerd-hrql) questionnaire and gastrointestinal symptom rating scale (gsrs), eating behavior with three-factor eating questionnaire before and one year after rygb. |
PubMedID- 25965137 | Multiple new endoluminal devices and therapies have been devised to create a more effective antireflux barrier in patients with gastroesophageal reflux disease (gerd). |
PubMedID- 25452843 | Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease. |
PubMedID- 24502186 | Introduction: treatment of persistence to proton pump inhibitors or non-acid reflux episodes in patients with gastroesophageal reflux disease is challenging. |
PubMedID- 24347282 | Efficacy, safety, and tolerability of pantoprazole magnesium in the treatment of reflux symptoms in patients with gastroesophageal reflux disease (gerd): a prospective, multicenter, post-marketing observational study. |
PubMedID- 26123332 | Methods and procedures: data on all patients undergoing poem were collected prospectively between august 2012 and june 2014 and included demographics, objective testing (48-h ph probe, manometry, endoscopy), as well as gastroesophageal reflux disease health-related quality of life (gerd-hrql), gerd symptom scale (gerss), and antacid use. |
PubMedID- 24481258 | Most physician respondents (79.2%) reported that they would treat chronic hoarseness with reflux medication in a patient without evidence of gastroesophageal reflux disease. |
Page: 1